Comparison between Clinitech Laboratory IPO and S A Tech Software IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while S A Tech Software IPO is a SME Bookbuilding proposed to list at NSE SME.
Clinitech Laboratory IPO | S A Tech Software IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price | Bookbuilding |
Listing At | BSE SME | NSE SME |
Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
Market Maker | Svcm Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | Anchor Investor ![]() | |
IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the S A Tech Software IPO is up to ₹21.33 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of S A Tech Software IPO is ₹59.00 per share.
Clinitech Laboratory IPO | S A Tech Software IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹56.00 per share | |
Issue Price (Upper) | ₹59.00 per share | |
Issue Price (Final) | ₹96.00 per share | ₹59.00 per share |
Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
Discount (Employee) | ||
Market Lot Size | 1200 shares | 2000 shares |
Fresh Issue Size | 5,71,200 shares | 36,16,000 shares |
Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹21.33 Cr |
OFS Issue Size | 0 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Issue Size Total | 5,71,200 shares | 36,16,000 shares |
Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹21.33 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while S A Tech Software IPO opens on Jul 26, 2024. The closing date of Clinitech Laboratory IPO and S A Tech Software IPO is Jul 29, 2024, and Jul 30, 2024, respectively.
Clinitech Laboratory IPO | S A Tech Software IPO | |
---|---|---|
Anchor Bid Date | Jul 25, 2024 | |
Issue Open | Jul 25, 2024 | Jul 26, 2024 |
Issue Close | Jul 29, 2024 | Jul 30, 2024 |
Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 31, 2024 |
Initiation of Refunds (Tentative) | Jul 31, 2024 | Aug 01, 2024 |
Credit of Share (Tentative) | Jul 31, 2024 | Aug 01, 2024 |
Listing date (Tentative) | Aug 01, 2024 | Aug 02, 2024 |
Anchor Lockin End date 1 | Aug 30, 2024 | |
Anchor Lockin End date 2 | Oct 29, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to S A Tech Software IPO P/E ratio of 14.65.
Clinitech Laboratory IPO | S A Tech Software IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| S A Tech Software India Limited Financial Information (Restated)S A Tech Software India Limited's revenue increased by 27.59% and profit after tax (PAT) rose by 266.7% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 83.63 | 79.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 61.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 43.45 | 14.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹21.91 Cr. | ₹77.04 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 10.95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.24 | 1.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.21 | ₹4.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 10.46% | 17.54% |
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in S A Tech Software IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 7,24,000 shares in S A Tech Software IPO.
Clinitech Laboratory IPO | S A Tech Software IPO | |
---|---|---|
Anchor Investor Reserveration | 10,82,000 shares | |
Market Maker Reserveration | 31,200 shares | 2,84,000 shares |
QIB | 7,24,000 shares | |
NII | 2,85,600 shares | 5,44,000 shares |
RII | 2,85,600 shares | 12,66,000 shares |
Employee | ||
Others | ||
Total | 5,71,200 shares | 36,16,000 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas S A Tech Software IPO subscribed 621.25x.
Clinitech Laboratory IPO | S A Tech Software IPO | |
---|---|---|
QIB (times) | 201.29x | |
NII (times) | 23.28x | 1,178.97x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 49.61x | 621.77x |
Employee (times) | ||
Other (times) | ||
Total (times) | 38.96x | 621.25x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O